Avenue Therapeutics Inc
0.03 (2.19%)
Company Name Stock Ticker Symbol Market Type
Avenue Therapeutics Inc ATXI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.03 2.19% 1.40 19:33:25
Open Price Low Price High Price Close Price Prev Close
1.36 1.34 1.435 1.38 1.37
more quote information »

Recent News

Date Time Source Heading
1/31/202313:09GLOBEAvenue Therapeutics Announces Closing of $3.25 Million..
1/27/202311:58GLOBEAvenue Therapeutics Announces $3.25 Million Registered..
1/25/202316:11EDGARCurrent Report Filing (8-k)
1/17/202309:09EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
1/06/202316:32EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
1/04/202317:49EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202311:02EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
1/04/202308:26EDGARStatement of Ownership (sc 13g)
12/14/202216:06EDGARAmended Statement of Ownership (sc 13g/a)
11/18/202216:31EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
11/18/202216:21EDGARProxy Statement (definitive) (def 14a)
11/10/202216:36EDGARQuarterly Report (10-q)
11/10/202216:31EDGARCurrent Report Filing (8-k)
11/10/202216:10GLOBEAvenue Therapeutics Reports Third Quarter 2022 Financial..
11/08/202208:41EDGARCurrent Report Filing (8-k)
11/08/202208:30GLOBEAvenue Therapeutics Completes the Acquisition of Baergic Bio..
10/19/202207:27EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
10/18/202217:20EDGARCurrent Report Filing (8-k)
10/17/202212:03EDGARStatement of Ownership (sc 13g)
10/17/202206:27EDGARStatement of Ownership (sc 13g)
10/12/202209:01EDGARCurrent Report Filing (8-k)
10/11/202214:15GLOBEAvenue Therapeutics Announces Closing of $12 Million..
10/11/202208:28EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
10/07/202206:04EDGARNotice of Effectiveness (effect)
10/06/202223:00GLOBEAvenue Therapeutics Announces Pricing of $12 Million..
10/06/202216:07EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
10/06/202208:05EDGARSecurities Registration Statement (s-1/a)
10/05/202210:56TRMNAvenue Therapeutics Tanks After Public Offering
10/05/202206:01EDGARSecurities Registration Statement (s-1/a)
10/03/202208:00GLOBEUrica Therapeutics Appoints Seasoned Biotech Executive Jay..
9/30/202216:32EDGARCurrent Report Filing (8-k)
9/27/202216:10TRMNWhy Avenue Therapeutics Stock’s (NASDAQ:ATXI) 107% Moonshot..
9/23/202207:25TRMNAvenue Therapeutics (NASDAQ:ATXI) in Focus on 1-for-15..
9/22/202216:25GLOBEAvenue Therapeutics Announces Reverse Stock Split and..
8/22/202216:31EDGARInformation Statement - All Other (definitive) (def 14c)
8/15/202217:16EDGARQuarterly Report (10-q)
8/12/202216:20EDGARCurrent Report Filing (8-k)
8/10/202217:16EDGARProxy Statement - Other Information (preliminary) (pre 14c)
8/03/202216:34EDGARInitial Statement of Beneficial Ownership (3)
8/03/202216:33EDGARCurrent Report Filing (8-k)
7/29/202216:32EDGARCurrent Report Filing (8-k)
7/28/202216:31EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
5/17/202217:10EDGARInitial Statement of Beneficial Ownership (3)
5/16/202216:26EDGARQuarterly Report (10-q)
5/13/202216:50EDGARCurrent Report Filing (8-k)
3/31/202207:30GLOBEAbeona Therapeutics Announces Strategy Update and 2021..
3/30/202217:03EDGARCurrent Report Filing (8-k)
3/25/202216:21EDGARAnnual Report (10-k)
3/08/202217:02EDGARCurrent Report Filing (8-k)
3/01/202212:47SEEKNVEE and IMPP among mid-day movers